That's why OpenAI's push to own the developer ecosystem end-to-end matters in26. "End-to-end" here doesn't mean only better models. It means the ...
EGFR-targeted therapy is often used in patients with EGFR-driven cancer but is limited by on-target/off-tumor toxicities. Here, the authors develop a bispecific antibody targeting both EGFR and B7-H3 ...
The loss of major health surveys once backed by the United States Agency for International Development and proposed cuts to environmental programs threaten the tracking of sustainable development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results